PF-06459988 is a novel, effective, orally active, irreversible, and selective epidermal growth factor receptor (EGFR) mutant inhibitor. PF-06459988 has high efficiency and high affinity for EGFRs double mutants containing T790M, and has minimal activity against WT EGFR. PF-06459988 makes a candidate drug for the treatment of cancer.
Molecular Weight:
431.88
Purity:
98.00%
CAS Number:
[1428774-45-1]
Formula:
C19H22ClN7O3
Target:
EGFR
T16492
* VAT and and shipping costs not included. Errors and price changes excepted